Mobia Medical (NASDAQ:MOBI) Price Target Raised to $17.00

Mobia Medical (NASDAQ:MOBI) had its price objective upped by JPMorgan Chase & Co. from $15.00 to $17.00 in a research report released on Wednesday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.

A number of other research analysts have also commented on the stock. Wolfe Research assumed coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They issued an “outperform” rating on the stock. The Goldman Sachs Group began coverage on Mobia Medical in a research note on Tuesday, June 2nd. They set a “buy” rating and a $31.00 target price for the company. Bank of America initiated coverage on Mobia Medical in a report on Tuesday, June 2nd. They issued a “buy” rating and a $16.00 target price for the company. BTIG Research reaffirmed a “buy” rating and issued a $19.00 price objective on shares of Mobia Medical in a research note on Wednesday. Finally, Wall Street Zen raised shares of Mobia Medical from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th. Five equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Mobia Medical currently has a consensus rating of “Moderate Buy” and an average price target of $20.75.

Mobia Medical Stock Up 0.7%

Shares of MOBI stock opened at $11.76 on Wednesday. The stock’s fifty day moving average is $12.44. The company has a market capitalization of $391.50 million and a P/E ratio of -0.61. The company has a debt-to-equity ratio of 0.04, a current ratio of 13.28 and a quick ratio of 5.55. Mobia Medical has a 12-month low of $10.19 and a 12-month high of $15.29.

Mobia Medical (NASDAQ:MOBI) last posted its quarterly earnings data on Tuesday, August 11th. The company reported ($1.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.27). The firm had revenue of $13.51 million for the quarter. The firm’s revenue for the quarter was up 102.4% on a year-over-year basis. On average, equities analysts expect that Mobia Medical will post -2.64 EPS for the current year.

Insider Activity at Mobia Medical

In other news, CFO Nelson Bunker Curnes acquired 5,000 shares of the stock in a transaction that occurred on Tuesday, June 9th. The shares were acquired at an average cost of $12.79 per share, for a total transaction of $63,950.00. Following the purchase, the chief financial officer owned 366,997 shares of the company’s stock, valued at approximately $4,693,891.63. The trade was a 1.38% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

About Mobia Medical

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.